Eradication of breast cancer cells in patients with distant metastasis: the finishing touches?
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Eradication of breast cancer cells in patients with distant metastasis: the finishing touches?
Authors
Keywords
-
Journal
Breast Cancer
Volume 19, Issue 3, Pages 206-211
Publisher
Springer Nature
Online
2011-04-27
DOI
10.1007/s12282-011-0266-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Survival differences among women with de novo stage IV and relapsed breast cancer
- (2010) S. Dawood et al. ANNALS OF ONCOLOGY
- Vascular Endothelial Growth Factor Secreted by Activated Stroma Enhances Angiogenesis and Hormone-Independent Growth of Estrogen Receptor–Positive Breast Cancer
- (2010) Mauricio P. Pinto et al. CANCER RESEARCH
- Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
- (2010) S. Riethdorf et al. CLINICAL CANCER RESEARCH
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
- (2010) F. Takahashi-Yanaga et al. CLINICAL CANCER RESEARCH
- The Difficulty of Targeting Cancer Stem Cell Niches
- (2010) M. A. LaBarge CLINICAL CANCER RESEARCH
- Cancer Stem Cells and Self-renewal
- (2010) C. A. O'Brien et al. CLINICAL CANCER RESEARCH
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- Hedgehog Pathway Antagonist 5E1 Binds Hedgehog at the Pseudo-active Site
- (2010) Henry R. Maun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
- (2010) O. Pagani et al. JNCI-Journal of the National Cancer Institute
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- More than Markers: Biological Significance of Cancer Stem Cell-Defining Molecules
- (2010) S. B. Keysar et al. MOLECULAR CANCER THERAPEUTICS
- Cues from steroid hormones
- (2010) John P. Lydon NATURE
- Therapeutic antibody targeting of individual Notch receptors
- (2010) Yan Wu et al. NATURE
- Control of mammary stem cell function by steroid hormone signalling
- (2010) Marie-Liesse Asselin-Labat et al. NATURE
- Progesterone induces adult mammary stem cell expansion
- (2010) Purna A. Joshi et al. NATURE
- Bmi-1, stem cells and cancer
- (2009) L. Jiang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Fifteen-year trends in metastatic breast cancer survival in Greece
- (2009) U. Dafni et al. BREAST CANCER RESEARCH AND TREATMENT
- Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group
- (2009) Kenichi Inoue et al. BREAST CANCER RESEARCH AND TREATMENT
- Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
- (2009) Marta Pestrin et al. BREAST CANCER RESEARCH AND TREATMENT
- Epithelial-mesenchymal transition in cancer development and its clinical significance
- (2009) Masaaki Iwatsuki et al. CANCER SCIENCE
- Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
- (2009) Bianca Mostert et al. CANCER TREATMENT REVIEWS
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
- (2009) A. Magnifico et al. CLINICAL CANCER RESEARCH
- Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
- (2009) Pepita Gimenez-Bonafe et al. CURRENT CANCER DRUG TARGETS
- The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: A systematic review
- (2009) Jacek Jassem et al. EUROPEAN JOURNAL OF CANCER
- Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients
- (2009) Janice Lu et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis
- (2009) Nastaran Z. Kuhn et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits?
- (2009) Ciara S. O’Brien et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
- (2009) Fatima Cardoso et al. JNCI-Journal of the National Cancer Institute
- Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer
- (2009) Seigo Nakamura et al. Breast Cancer
- Breast cancer stem cells
- (2009) Kazuharu Kai et al. Breast Cancer
- HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer
- (2008) Julie E. Lang et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
- (2008) Mitra Tewes et al. BREAST CANCER RESEARCH AND TREATMENT
- Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse
- (2008) F.-C. Bidard et al. CLINICAL CANCER RESEARCH
- Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
- (2008) Andrew D. Seidman et al. JOURNAL OF CLINICAL ONCOLOGY
- Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
- (2008) Silvia Dellapasqua et al. JOURNAL OF CLINICAL ONCOLOGY
- Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy
- (2008) A. M. Brewster et al. JNCI-Journal of the National Cancer Institute
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
- (2008) Soonmyung Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
- Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2008) I. J. Dahabreh et al. ONCOLOGIST
- Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues
- (2007) A Vincent-Salomon et al. JOURNAL OF CLINICAL PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More